A promising research on cancer treatment will be presented to investors
The technology from MUNI was chosen for Academic Innovators presentation at BIO-Europe Spring 2019. Our researcher Vítězslav Bryja is going to speak about promising research of highly potent and selective inhibitors of CK1 kinases for the treatment of leukemias, lymphomas and solid tumors. TTO MUNI is looking for a research partner and a licensee for this technology.
Share article
More articles
-
TTO MUNI wishes you a successful year filled with great ideas
Pour féliciter 2019
-
BioFIT conference attended by Masaryk University
The conference was held in Lille, France
-
TT Day introduced trademark Antarctica and the Hypothesis system
More than sixty guests visited the event
-
Seminar on biotech startups had a great response
The Life after PhD series was attended by 40 listeners